SCHEMBL19563697

SCHEMBL19563697

Cc1cc(P)ccc1Oc1ccc(C(F)(F)F)cc1C(=O)Nc1cccc(S(N)(=O)=O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16398916 0.90 — —
SCHEMBL16408269 0.90 — —
SCHEMBL17791068 0.90 — —
SCHEMBL16408278 0.84 — —
SCHEMBL17791071 0.84 — —
SCHEMBL16408268 0.84 — —
SCHEMBL17791069 0.82 — —
SCHEMBL16408303 0.82 — —
SCHEMBL16408306 0.82 — —
SCHEMBL16408305 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3022175-B1 SULFONAMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMA (US) 2017-11-08 — — EP disclosed
Send feedback